Early clinical outcomes of the domestic KokaclipTM transcatheter edge-to-edge mitral valve repair system for severe degenerative mitral regurgitation:A single-arm,prospective,single-group target value clinical trial
Objective To summarize and analyze the preliminary clinical outcomes of the KokaclipTM transcatheter edge-to-edge mitral valve repair system for severe degenerative mitral regurgitation(DMR).Methods This study was a single-arm,prospective,single-group target value clinical trial that enrolled patients who underwent the KokaclipTM transcatheter edge-to-edge repair(TEER)system for DMR in the Department of Heart Surgery of Guangdong Provincial People's Hospital,Guangdong Cardiovascular Institute from June 2022 to January 2023.Differences in the grade of mitral regurgitation(MR)during the perioperative and follow-up periods were compared,and the incidences of adverse events such as all-cause death,thoracotomy conversion,reoperation,and severe recurrence of MR during the study period were investigated.Results The enrolled patient population consisted of 14(50.0％)females with a mean age of 70.9±5.4 years.Twenty-eight(100.0％)patients were preoperatively diagnosed with type Ⅱ DMR,with a prolapse width of 12.5(11.0,16.1)mm,a degree of regurgitation 4+leading to pulmonary venous reflux,and a New York Heart Association cardiac function class≥Ⅲ.All patients completed the TEER procedure successfully,with immediate postoperative improvement of MR to 0,1+,and 2+grade in 2(7.1％),21(75.0％),and 5(17.9％)patients,respectively.Mitral valve gradient was 2.5(2.0,3.0)mm Hg.Deaths,thoracotomy conversion,or device complications such as unileaflet clamping,clip dislodgement,or leaflet injury were negative.Twenty-eight(100.0％)patients completed at least 3-month postoperative follow-up with a median follow-up time of 5.9(3.6,6.8)months,during which patients had a mean MR grade of 1.0+(1.0+,2.0+)grade and a significant improvement from preoperative values(P＜0.001).There was no recurrence of ≥3+regurgitation,pulmonary venous reflux,reoperation,new-onset mitral stenosis,or major adverse cardiovascular events.Twenty-two(78.6％)patients'cardiac function improved to class Ⅰ orⅡ.Conclusion The domestic KokaclipTM TEER system has shown excellent preliminary clinical results in selected DMR patients with a high safety profile and significant improvement in MR.Additional large sample volume,prospective,multicenter studies,and long-term follow-up are expected to validate the effectiveness of this system in the future.
Transcatheter edge-to-edge repairdegenerative mitral regurgitationultrasonic guidanceclinical outcomesprospective study
万方数据
